European CRO Offering Clinical Research and Support Services in Europe and the US
12 Building 1, Krivokolennyi per, Moscow 101000, Russia
Atlant Clinical is a contract research organisation (CRO) providing efficient clinical research and support services for Phase I-IV clinical trials in Russia, Europe, and the US.
An effective and experienced international CRO in Europe, Atlant Clinical helps its clients optimise research and development (R&D) investments to help deliver innovative drugs and medical devices.
Atlant Clinical employs an international team of more than 150 experienced professionals and focuses on development of its staff to ensure each client receives high-quality, expert guidance.
Atlant Clinical’s specialists provide an array of scientific and medical expertise, including services such as translation and adaptation of trial documentation, preparation of clinical study reports and other records, development of medical and scientific articles for international and local peer-review journals, and formation of patient-doctor diaries and questionnaires.
The company provides these services in strict compliance with good clinical practice (GCP) and all applicable international and local regulatory requirements.
Atlant Clinical provides project management services for pharmaceutical development projects, which are performed by its most experienced professionals. The company’s dedicated project managers undergo regular trainings to ensure they provide end-to-end support.
Guidance is provided throughout every stage of clinical trials in Europe, from site selection and review of regulatory documents in trial initiation to clinical monitoring in accordance with standard operating procedures (SOP) and the International Conference on Harmonisation’s (ICH) GCP.
As part of its site management offering, Atlant Clinical tracks the progression of trial participants and ensures there are no violations of study protocols or regulatory requirements.
The company also assists with logistics management for drugs and supplies, as well as site personnel education and training.
In addition, Atlant helps prevent serious adverse events thorough assessment and reporting to ensure trials are safe for both patients and researchers.
To provide full support and guidance, Atlant Clinical’s logistics management services include obtaining of importation / exportation licences; the preparation of customs documentation; and the import, distribution, storage, relabelling, return, and destruction of a wide variety of clinical trial materials. The company also exports biological samples to a central laboratory.
In addition, Atlant helps select appropriate vendors, identifying and utilising professional, high-quality service providers. The company uses its extensive industry knowledge to ensure effective collaborations with suitable partners.
As a European CRO, Atlant Clinical offers a range of services to expedite state review of study documentation and issuance of all necessary legal study approvals, including:
Atlant Clinical provides a full range of data management and biostatistics services for clinical trials in Europe and clinical trials in the US, including:
Being certified by international organisations, auditors of Atlant Clinical provide consulting and contract audits of investigational sites, vendors, Phase I units, SOPs and trial master files (TMF), with respect to their correspondence to applicable local regulation and international guidelines.
Atlant Clinical has an effective internal training department, which educates its staff on the latest industry trends, relevant regulations, best practices, and other issues. These courses allow Atlant to maintain one of the most professional teams on the market. The company also offers the courses as a stand-alone service to external industry professionals.
Atlant’s training courses combine theoretical and real-life cases from the company’s own abundant experience in clinical operations.
Atlant Clinical is a European CRO that demonstrates steady dynamics. The company continuously expands its service offering and geography of operations. Its team currently includes around 150 experts in clinical research worldwide and the company continues to hire ambitious and talented specialists.
Atlant Clinical has recently expanded to the UK, the US, Germany, Lithuania, and Russia.
Atlant Clinical provides end-to-end services, including clinical advisory, medical and scientific writing, regulatory support, clinical monitoring, project management, biostatistics and data management, as well as other professional activities.
In June 2017, Siemens Healthineers initiated the expansion and refurbishment of its laboratory diagnostic manufacturing facility located in Walpole, Massachusetts, US.
Colorado State University (CSU) began construction of the C. Wayne McIlwraith Translational Medicine Institute (TMI) in June 2017.
CureVac is developing a new good manufacturing practice (GMP) compliant ribonucleic acid (RNA) production facility at its German headquarters in Tubingen
The Davis Companies (TDC) has developed a new research centre in West Cambridge, Massachusetts.
The Imaging Centre of Excellence (ICE) at the Queen Elizabeth University Hospital (QEUH) in Scotland was inaugurated in March 2017.
Atlant Clinical is celebrating two years of excellence in providing out-tasking services to a large pharmaceutical company.
Having successfully started the year with exhibiting at SCOPE Summit in February, Atlant Clinical continues to take part in major events in the US clinical field.
Atlant Clinical announces winning a tender held by an international pharmaceutical company to conduct a multicenter Phase III clinical trial in vascular medicine. The study will be conducted in Russia, Belarus, Georgia, Ukraine and Kazakhstan.
Atlant Clinical has announced it will host its second MedDRA training in May 2018 following a major success of the first MedDRA face-to-face meeting organised in close collaboration with Atlant Clinical.
Atlant Clinical has successfully completed an international, multicenter, randomised, placebo-controlled study in patients with cystic fibrosis.
Atlant Clinical has successfully completed an international, multicenter, double-blind, placebo-controlled, Phase IIIa study in patients with prostate cancer.
Atlant Clinical has become a sponsor for regular Life Science & Healthcare conferences organised by YJP.
12 Building 1
Krivokolennyi per
Moscow 101000
Russia
76 N. Walnut Street
Ridgewood, NJ 07450
United States of America
Josephspitalstr. 15
80331 Munich
Germany
Palladium House
1-4 Argyll Street
W1F 7LD
London
United Kingdom
Yevhena Konovaltsia St, 36
01133, Kyiv
Ukraine